Haihe Biopharma Co., Ltd.

This study tests a new drug called CYH33 in people with rare conditions that cause abnormal tissue growth and blood vessel malformations (PROS and PRVM). The trial has two phases: phase I finds the safest dose, and phase II checks if the drug shrinks growths. About 141 adults and…

This study tests an experimental oral drug called HH2853 in about 100 people with peripheral T-cell lymphoma that has come back or not responded to prior treatments. The drug works by blocking certain proteins that help cancer cells grow. The goal is to see if it can shrink tumor…

This study tests an experimental drug called HH2853 in people with certain types of blood cancer (non-Hodgkin lymphoma) or advanced solid tumors that have come back or stopped responding to treatment. The drug is taken as a tablet twice a day. The main goals are to find the safes…